BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 6203834)

  • 41. Experimental IgA nephropathy. Factors governing the persistence of IgA-antigen complexes in the circulation of mice.
    Rifai A; Small P; Ayoub EM
    Contrib Nephrol; 1984; 40():37-44. PubMed ID: 6499461
    [No Abstract]   [Full Text] [Related]  

  • 42. Nephritogenicity and differential distribution of glomerular immune complexes related to immunogen charge.
    Gallo GR; Caulin-Glaser T; Emancipator SN; Lamm ME
    Lab Invest; 1983 Mar; 48(3):353-62. PubMed ID: 6338294
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Measles and acute glomerulonephritis.
    Lin CY; Hsu HC
    Pediatrics; 1983 Mar; 71(3):398-401. PubMed ID: 6219335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mouse model of membranous nephropathy induced by cationic bovine serum albumin: antigen dose-response relations and strain differences.
    Chen JS; Chen A; Chang LC; Chang WS; Lee HS; Lin SH; Lin YF
    Nephrol Dial Transplant; 2004 Nov; 19(11):2721-8. PubMed ID: 15385633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monomeric immunoglobulin A protects glomerulus against polymeric immunoglobulin A immune complex in experimental immunoglobulin A nephropathy.
    Chen A; Sheu LF; Ding SL; Lee WH
    Lab Invest; 1996 Apr; 74(4):737-46. PubMed ID: 8606484
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dietary fat and immune function. II. Effects on immune complex nephritis in (NZB x NZW)F1 mice.
    Yumura W; Hattori S; Morrow WJ; Mayes DC; Levy JA; Shirai T
    J Immunol; 1985 Dec; 135(6):3864-8. PubMed ID: 2933453
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nephritogenic immune reactions involving immune complex formation in the circulation and in situ within the kidney.
    Wilson CB; Neale TJ; Holdsworth SR
    Aust N Z J Med; 1981; 11(Suppl 1):88-93. PubMed ID: 6455118
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monoclonal antibodies to carcinoembryonic antigen: a systematic analysis of antibody specificities by using related normal antigens and evidence for allotypic determinants on carcinoembryonic antigen.
    Kuroki M; Kuroki M; Koga Y; Matsuoka Y
    J Immunol; 1984 Oct; 133(4):2090-7. PubMed ID: 6206151
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-Thy-1 monoclonal antibody-induced glomerulonephritis in Mongolian gerbils.
    Sato H; Chisty M; Kamiya H
    Comp Med; 2000 Dec; 50(6):603-8. PubMed ID: 11200565
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immune complex glomerulonephritis in baboons (Papio cynocephalus) with indwelling intravascular catheters.
    Leary SL; Sheffield WD; Strandberg JD
    Lab Anim Sci; 1981 Aug; 31(4):416-20. PubMed ID: 6458737
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Immune complexes: studies on animal models].
    Albini B; Penner E; Knoflach P
    Wien Klin Wochenschr; 1985 Apr; 97(8):363-9. PubMed ID: 3158121
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An assessment of the influence of antigen dose in two new models of chronic serum sickness glomerulonephritis in the rat.
    Furness PN; Turner DR
    Br J Exp Pathol; 1987 Aug; 68(4):527-38. PubMed ID: 3651324
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Etiologic agents of immune-deposit disease.
    Roy LP; Fish AJ; Michael AF; Vernier RL
    Prog Clin Immunol; 1972; 1():1-22. PubMed ID: 4142093
    [No Abstract]   [Full Text] [Related]  

  • 55. Tissue deposition of immune complexes in mice receiving daily injections of bovine serum albumin.
    Noble B; Olson KA; Milgrom M; Albini B
    Clin Exp Immunol; 1980 Nov; 42(2):255-62. PubMed ID: 6451337
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A possible role for idiotypic interactions in the pathogenesis of immune complex glomerulonephritis.
    Lambert PH; Goldman M; Rose LM; Morel PA
    Transplant Proc; 1982 Sep; 14(3):543-6. PubMed ID: 6184861
    [No Abstract]   [Full Text] [Related]  

  • 57. Experimental chronic serum sickness in rats. A model of immune complex glomerulonephritis and systemic immune complex deposition.
    Arisz L; Noble B; Milgrom M; Brentjens JR; Andres GA
    Int Arch Allergy Appl Immunol; 1979; 60(1):80-8. PubMed ID: 156700
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proliferative glomerulonephritis in mice given intravenous Corynebacterium parvum.
    Uff JS; Mitcheson HD; Pussell BA; Brill M; Castro JE
    J Pathol; 1981 Feb; 133(2):89-105. PubMed ID: 6451676
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immune complex disease. V. The nature of the circulating complexes associated with glomerular alterations in the chronic BSA-rabbit system.
    Germuth FG; Senterfit LB; Dreesman GR
    Johns Hopkins Med J; 1972 Jun; 130(6):344-57. PubMed ID: 5031005
    [No Abstract]   [Full Text] [Related]  

  • 60. Treatment of experimental immune complex glomerulonephritis by sodium alginate.
    Mirshafiey A; Borzooy Z; Abhari RS; Razavi A; Tavangar M; Rehm BH
    Vascul Pharmacol; 2005 Jun; 43(1):30-5. PubMed ID: 15893960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.